Best Building Product Stocks To Watch Right Now

Popular Posts: 9 Biotechnology Stocks to Buy Now17 Oil and Gas Stocks to Sell Now5 Oil and Gas Stocks to Buy Now Recent Posts: 4 Capital Markets Stocks to Sell Now 3 Medical Devices Stocks to Sell Now 4 Building Products Stocks to Buy Now View All Posts

The overall ratings of four capital markets stocks are down on Portfolio Grader this week. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).

This week, Investment Technology Group, Inc. () falls to a D (“sell”), worse than last week’s grade of C (“hold”). Investment Technology Group is an agency brokerage and financial technology firm that partners with asset managers globally to provide innovative solutions spanning the investment continuum. In Portfolio Grader’s specific subcategories of Earnings Growth, Cash Flow and Sales Growth, ITG also gets an F. The stock’s trailing PE Ratio is 51.00. .

Best Building Product Stocks To Watch Right Now: Boston Scientific Corp (BSX)

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. During the year ended December 31, 2011, its products were offered for sale by seven core businesses: Interventional Cardiology, CRM, Endoscopy, Peripheral Interventions, Urology/Women��s Health, Neuromodulation, and Electrophysiology. In January 2011, it completed the acquisition of Intelect Medical, Inc. In January 2011, it completed the acquisition of Sadra Medical, Inc. In March 2011, the Company completed the acquisition of Atritech, Inc. In February 2011, it announced the acquisitions of S.I. Therapies and ReVascular Therapeutics, Inc. In January 2011, the Company sold its Neurovascular business to Stryker Corporation. In June 2012, the Company acquired Cameron Health, Inc. of San Clemente, California and, as a result, added to its product portfolio subcutaneous implantable cardioverter defibrillator, called the S-ICD System.

Interventional Cardiology

The Company offers coronary stent product. Coronary stents are tiny, mesh tubes used in the treatment of coronary artery disease, which are implanted in patients to prop open arteries and facilitate blood flow to and from the heart. The Company offers a two-drug platform strategy with its paclitaxel-eluting and everolimus-eluting stent system offerings, and it offers a range of stent sizes. The Company markets its next-generation internally-developed and self-manufactured PROMUS Element stent system in the United States, its Europe/Middle East/Africa (EMEA) region and certain Inter-Continental countries, including China and India. It markets the PROMUS everolimus-eluting stent system, supplied to the Company by Abbott Laboratories, in Japan. It also markets its TAXUS paclitaxel-eluting stent line, including its third-generation TAXUS Element paclitaxel-eluting stent system in the U.nited States, Japan, EMEA and certain Inter-Continental countries.

The Compa! ny markets a line of products used to treat patients with atherosclerosis, a principal cause of coronary artery obstructive disease. Its product offerings include balloon catheters, rotational atherectomy systems, guide wires, guide catheters, embolic protection devices, and diagnostic catheters used in percutaneous transluminal coronary angioplasty (PTCA). The Company markets a family of intraluminal catheter-directed ultrasound imaging catheters and systems for use in coronary arteries and heart chambers, as well as certain peripheral vessels. The iLab Ultrasound Imaging System continues as its flagship console and is compatible with its line of imaging catheters. The system is designed to enhance the diagnosis and treatment of blocked vessels and heart disorders. Sadra is developing a repositionable and retrievable device for transcatheter aortic valve replacement (TAVR) to treat patients with severe aortic stenosis. The Lotus Valve System consists of a stent-mounted tissue valve prosthesis and catheter delivery system for guidance and placement of the valve. Atritech has developed a device designed to close the left atrial appendage in patients with atrial fibrillation who are at risk for ischemic stroke. The WATCHMAN Left Atrial Appendage Closure Technology, developed by Atritech, is the first device proven in a randomized clinical trial to offer an alternative to anticoagulant drugs, and is approved for use in CE Mark countries.

Cardiac Rhythm Management

The Company develops, manufactures and markets a variety of implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, including Implantable cardioverter defibrillator (ICD) systems used to detect and treat abnormally fast heart rhythms (tachycardia) that could result in sudden cardiac death, including implantable cardiac resynchronization therapy defibrillator (CRT-D) systems used to treat heart failure, and implantable pacemaker systems used to manage slow or irregular heart rhyth! ms (brady! cardia), including implantable cardiac resynchronization therapy pacemaker (CRT-P) systems used to treat heart failure. Its product offerings include its COGNIS cardiac resynchronization therapy defibrillator (CRT-D), its TELIGEN ICD systems and its ALTRUA family of pacemaker systems. During 2011, it began the United States launch of its next-generation line of defibrillators, INCEPTA, ENERGEN and PUNCTUA.

Endoscopy

The Company markets a range of products to diagnose, treat and ease a variety of digestive diseases, including those affecting the esophagus, stomach, liver, pancreas, duodenum, and colon. Common disease states include esophagitis, portal hypertension, peptic ulcers as well as esophageal, biliary, pancreatic and colonic cancer. The Company offers the Radial Jaw 4 Single-Use Biopsy Forceps, which are designed to enable collection of large high-quality tissue specimens without the need to use large channel therapeutic endoscopes. Its exclusive line of RX Biliary System devices are designed to provide greater access and control for physicians to diagnose and treat challenging conditions of the bile ducts, such as removing gallstones, opening obstructed bile ducts and obtaining biopsies in suspected tumors. The Company also markets the Spyglass Direct Visualization System for direct imaging of the pancreatico-biliary system. The Spyglass System is a single-operator cholangioscopy device that offers clinicians a direct visualization of the pancreatico-biliary system and includes supporting devices for tissue acquisition, stone management and lithotripsy. Its products also include the WallFlex family of stents, in particular, the WallFlex Biliary line and WallFlex Esophageal line; and in 2011, the Company launched its Advanix Biliary Plastic Stent System and the Expect Endoscopic Ultrasound Aspiration Needle in the United States and certain international markets. Its Resolution Clip Device is an endoscopic mechanical clip designed to treat gastrointestinal bleeding.

T! he Company markets devices to diagnose, treat and ease pulmonary disease systems within the airway and lungs. Its products are designed to help perform biopsies, retrieve foreign bodies from the airway, open narrowings of an airway, stop internal bleeding, and ease symptoms of some types of airway cancers. Its product line includes pulmonary biopsy forceps, transbronchial aspiration needles, cytology brushes and tracheobronchial stents used to dilate narrowed airway passages or for tumor management. Asthmatx, Inc. designs, manufactures and markets a less-invasive, catheter-based bronchial thermoplasty procedure for the treatment of severe persistent asthma. The Alair Bronchial Thermoplasty System, developed by Asthmatx, has both CE Mark and Food and Drug Administration (FDA) approval and is the first device-based asthma treatment approved by the FDA.

Peripheral Interventions

The Company sells various products designed to treat patients with peripheral disease, including a line of medical devices used in percutaneous transluminal angioplasty and peripheral vascular stenting. Its peripheral product offerings include stents, balloon catheters, wires, peripheral embolization devices and vena cava filters. In 2010 and 2011, it launched several of its products internationally, including the EPIC self-expanding nitinol stent system in certain international markets, and the Carotid WALLSTENT stent system in Japan. The Company launched three new peripheral angioplasty balloons in 2011, including its next-generation Mustang percutaneous transluminal angioplasty (PTA) balloon, its Coyote balloon catheter, a highly deliverable and ultra-low profile balloon dilatation catheter designed for a range of peripheral angioplasty procedures and its Charger PTA Balloon Catheter, a 0.035 inch percutaneous transluminal angioplasty balloon catheter designed for post-stent dilatation, as well as conventional balloon angioplasty to open blocked peripheral arteries. The Company has commenced a limited ma! rket rele! ase of its OFFROAD re-entry catheter system in certain international markets, and in February 2012, it launched its TRUEPATH intraluminal CTO device in the United States.

The Company sells products designed to treat patients with non-vascular disease. Its non-vascular suite of products include biliary stents, drainage catheters and micro-puncture sets designed to treat, diagnose and ease various forms of benign and malignant tumors. The Company continues to market its extensive line of Interventional Oncology product solutions, including the Renegade HI-FLO Fathom microcatheter and guidewire system and Interlock - 35 Fibered IDC Occlusion System for peripheral embolization. The Company��s FilterWire EZ Embolic Protection System is a filter designed to capture embolic material that may become dislodged during a procedure, which could otherwise travel into the microvasculature where it could cause a heart attack or stroke. It is commercially available in the United States, its EMEA region and certain Inter-Continental countries for multiple indications, including the treatment of disease in peripheral, coronary and carotid vessels. It is also available in the United States for the treatment of saphenous vein grafts and carotid artery stenting procedures.

Urology/Women��s Health

The Company��s Urology/Women��s Health division develops, manufactures and sells devices to treat various urological and gynecological disorders. The Company sells a variety of products designed to treat patients with urinary stone disease, stress urinary incontinence, pelvic organ prolapse and excessive uterine bleeding. The Company offers a line of stone management products, including ureteral stents, wires, lithotripsy devices, stone retrieval devices, sheaths, balloons and catheters.

The Company markets a range of devices for the treatment of conditions, such as female urinary incontinence, pelvic floor reconstruction (rebuilding of the anatomy to its original state), and ! menorrhag! ia (excessive menstrual bleeding). It offers a breadth of mid-urethral sling products, sling materials, graft materials, pelvic floor reconstruction kits, and suturing devices. The Company markets its Genesys Hydro ThermAblator (HTA) system, a next-generation endometrial ablation system designed to ablate the endometrial lining of the uterus in premenopausal women with menorrhagia. The Genesys HTA System features a smaller and lighter console, simplified set-up requirements, and an enhanced graphic user interface and is designed to improve operating performance.

Neuromodulation

The Company within its Neuromodulation business markets the Precision Spinal Cord Stimulation (SCS) system, used for the management of chronic pain. In 2011, the Company launched its Clik Anchor for its Precision Plus SCS System, a rechargeable SCS device for chronic pain management. During 2011, it received FDA approval for and launched the Infinion 16 Percutaneous Lead, a 16-contact percutaneous lead. The Company also markets the Linear 3-4 and Linear 3-6 Percutaneous Leads for use with its SCS systems, which are designed to provide physicians more treatment options for their chronic pain patients. Intelect Medical, Inc. is a development-stage company developing advanced visualization and programming for the Vercise system.

Electrophysiology

The Company within its Electrophysiology business develops less-invasive medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart. Included in its product offerings are radio frequency (RF) generators, steerable RF ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, and other accessories. Its products include the Blazer and Blazer Prime line of temperature ablation catheters, designed to deliver enhanced performance, responsiveness, and durability. Its cooled ablation portfolio includes the closed-loop irrigated catheter on the market, the Chilli II cooled! ablation! catheter, and the newly launched Blazer Open-Irrigated ablation catheter with a Total Tip Cooling Design.

The Company competes with Abbott Laboratories, Medtronic, Inc., St. Jude Medical, Inc. and Johnson & Johnson.

Advisors' Opinion:

• [By Vera Yuan]

  ��Medical device manufacturer Boston Scientific Corp. (BSX) reported solid earnings for the first quarter but investors focused on near-term headwinds in the cardiac-rhythm management business. The company also announced a delay in potential approval for its Watchman��s heart device. Given the breadth of the company��s pipeline, potential for margin upside, and attractive valuation, we continue to like the outlook for the shares going forward.From Diamond Hill Capital (Trades, Portfolio)'s Select Fund Second Quarter 2014 Commentary.Also check out: Diamond Hill Capital Undervalued Stocks Diamond Hill Capital Top Growth Companies Diamond Hill Capital High Yield stocks, and Stocks that Diamond Hill Capital keeps buying Currently 0.00/512345

  Rating: 0.0/5 (0 votes)

Best Building Product Stocks To Watch Right Now: Clicksoftware Technologies Ltd (CKSW)

ClickSoftware Technologies Ltd. (ClickSoftware), incorporated in 1979, is a provider of software products and solutions for workforce management and optimization for the service sector. The Company derives revenues from the licensing of its software products and the provision of consulting and support services. It also generates revenues from Cloud-based solutions. under software as a service (SaaS) model. ClickSoftware��s solutions are grouped into four main suites which together comprise its Service Optimization Suite: Field Service Daily Suite, Mobility Suite, Roster (Shift Planning) Suite and Forecasting and Planning Suite. Additionally, it offers variations of its products for certain vertical markets, including Mid-Market Package - Installation, Maintenance and Repair Services (ClickIMRS) and Service Tycoon. Its products include: ClickSchedule, ClickAnalyze, ClickLocate, ClickContact, ClickRoster, ClickPlan, and ClickForecast. In March 2014, the Company acquired Xora Inc., a cloud-based mobile workforce management.

Field Service Daily Suite covers automatic decision making and optimization support to manage field service operations: commencing from appointment booking and scheduling during the period around the day of service, followed by real time scheduling and optimization during the day of service and culminating with reports and business metrics analytics after the day of service. Roster (Shift Planning) Suite covers shift planning needs for both the manager, as well as the employee to optimize the balance between staffing levels needed for serving customers and managing labor costs, and employee preferences. This suite is offered in several configurations for different industry verticals ranging from police forces to contact centers, and more. Mobility Suite covers the needs of the mobile individual and back-office staff for field data communication, such as sending jobs from the back office to the person��s hand-held device, and the person��s ability to accept/decline the ! job, report on progress and job completion, as well as capturing customers�� signatures, or sending the person��s own time sheet to the back office. Geography support, such as travel guidance and information about underground equipment are also covered.

ClickSchedule optimizes service scheduling and routing to improve workforce productivity by balancing customer, service and asset resources, and organizational preferences, including contractual commitments, priority, drive time, skills, and service and asset resources availability. ClickAnalyze provides reporting, monitoring and service business analytics for workforce performance measurement and strategic decision support. It enables analysis of key performance indicators, including resource productivity, operational costs, and responsiveness to customers.

ClickLocate (LBS) captures the location information of a field service engineer and/or his or her vehicle obtained via GPS or other technology and integrates it with ClickSchedule for use in optimized scheduling. LBS then enables service organizations to improve their service operations by allowing them to make decisions and take actions based on location information, including near real-time engineer locations. ClickContact is a customer interaction management solution that enables self-service appointment booking, order updating, automatic customer notifications and customer satisfaction surveying. From scheduling the initial appointment through enabling a post-service follow-up survey, ClickContact provides customer interaction management throughout the service lifecycle.

ClickRoster provides interactive and automated workforce shift planning based on forecasted workload by quantities and skill requirements, rules and regulations, working contracts, engineer skills, calendar and preferences. ClickPlan provides interactive and automated workforce planning for staffing and deployment of the field workforce based on forecasted workload. It is designed ! to enable! service organizations to resolve workforce shortages and surpluses weeks and months in advance. ClickForecast provides field service workload forecasting to enable companies to project workforce capacity. It enables service managers, marketing, and sales to determine the demand levels of customers, and to create multiple forecast scenarios, each with different business assumptions. (ClickIMRS) is a pre-configured package that has been tailored to the needs of small and mid-sized companies. ClickIMRS features pre-configured scheduling and reporting that reduces the expense, time and effort required to custom-design and program schedules and reports. In addition, the ready-to-use reports provide insight into service operations and streamline decision-making on the part of both service management and dispatchers.

ClickSoftware Cloud Services include two Web-based offerings of its complete Service Optimization Suite. ClickCloud offers medium and market enterprise customers an alternative to on-premises deployment of the Service Optimization Suite. ClickCloud also enables a hybrid information technology (IT) model, which is a solution comprised of a mix of Cloud and on-premises deployment ClickExpress offers the customers to be up and running within a relatively short period of time, with its products.

Advisors' Opinion:

• [By Evan Niu, CFA]

  What: Shares of ClickSoftware (NASDAQ: CKSW  ) have plunged today by as much as 13% after the company warned that second-quarter results would fall short of expectations.

• [By Sean Williams]

  Optimize your buying
  Software companies these days are being judged not just by how many new contracts they gained during the current quarter, but by how well they're prepared to deal with the transition to cloud platforms. Supply-chain and workforce-optimization software developer ClickSoftware Technologies (NASDAQ: CKSW  ) looks well poised to take advantage of these trends and has no business, in my opinion, being anywhere near a 52-week low.

Top Managed Healthcare Companies To Invest In Right Now: Entest Biomedical Inc (ENTB)

Entest BioMedical, Inc. (Entest), incorporated on September 24, 2008, is a development-stage company. During the fiscal year ended August 31, 2012, the Company��s business consists of the development and commercialization of immunotherapeutic therapies for the veterinary market, as well as the acquisition and operation of veterinary hospitals. The Company is focusing its research and development efforts toward the development and commercialization of the ImenVax family of canine cancer vaccines. ImenVax I is a therapeutic for canine cancer, which involves isolating tumor cells from the patient and then placing the cells into a cell implant device that is inserted subcutaneously into the patient. ImenVax II, which utilizes cell lines for sustained release of immunologically relevant cytokines for maximum anti-tumor immune responses.

ImenVax

The Company is conducting a ten dog safety study to Evaluate ImenVax I for the Treatment of Canine Oral Melanoma. As of May 17, 2012 three dogs suffering from oral melanoma have been administered the therapy with no dog suffering any material adverse reaction.

ImenVax II

The Company intends to include adjuvant cytokine along with tumor cells into the implantation device. The adjuvants can be added through cytokine expressing cell line.

ImenVax III

ImenVax III is intended to function by harnessing the ability of placental extracts to combat canine cancers. ImenVax III is intended to treat existing tumors through stimulation of immune responses to kill tumor cells directly; indirectly kill tumor cells by cutting off the tumor blood supply, and block the ability of the tumor to suppress the immune system.

ENT-576

ENT-57 is a therapy being developed by the Company for the treatment of Chronic Obstructive Pulmonary Disease (COPD), such therapy consists of extracting a therapeutic number of cells from a tissue containing in part a stem cell population; processing sai! d population of cells derived from said tissue so as to concentrate said stem cell population; systemic re-administration of said cell population into the same patient, and exposing the patient lung to a sufficient intensity and frequency of laser irradiation necessary to augment therapeutic activity of said cells in said patient suffering from COPD. A therapeutic intervention in COPD would require addressing the issues of inflammation and regeneration.

Advisors' Opinion:

• [By Peter Graham]

  Small cap mining stocks US Tungsten Corp (OTCMKTS: USTU) and LKA Gold Inc (OTCMKTS: LKAI) along with biotech Entest BioMedical Inc (OTCMKTS: ENTB) have been getting some attention lately in various investment newsletters with at least one of these stocks being the subject of paid promotions while another could soon be the subject of an investor relations campaign. But will any of these small cap stocks be winners for investors or traders? Here is a quick reality check:

Best Building Product Stocks To Watch Right Now: Xyratex Ltd.(XRTX)

Xyratex Ltd provides modular solutions for the enterprise data storage industry and hard disk drive (HDD) capital equipment for the HDD industry. It offers enterprise data storage solutions that include storage enclosures, which provide a common technology platform that reduces qualification time for original equipment manufacturer (OEM) customers and includes management interface software, standardized across enclosures, and provides easy integration as new platforms; integrated application platforms that comprise embedded storage platforms, which incorporate embedded server modules into its storage enclosures; and HPC Solutions that consolidate controllers, storage enclosures, application platforms, operating system, data protection, Lustre File System, and management software into a optimized scale-out storage platform that can be deployed in hours rather than weeks. The company also designs and manufactures a range of process test systems, which incorporate mechanical and electronic hardware, and firmware for controlling the HDD operating environment during the formatting of the disk drive. In addition, it provides automated solutions comprising substrate and media inspection systems; servo track writers and related subassemblies; and head testing systems that test and process HDD components throughout the manufacturing process. The company markets and sells its products primarily to OEMs and disk drive manufacturers, as well as to other companies in North America, Asia, and Europe. Xyratex Ltd was founded in 1966 and is headquartered in Havant, the United Kingdom.

Advisors' Opinion:

• [By Jonathan Fishman]

  Two weeks ago an SA contributor, Kingsley Park Capital, pointed out that shares of Xyratex (XRTX) have a 70% upside. I suggest KPC is being conservative. I think its opinion is priceless, but I would like to offer my financial model to support this thesis and show that the moment the market realizes what's going on, XRTX should be worth $20-$30 a share a year or so from now. Let's get started.

• [By Lisa Levin]

  Xyratex (NASDAQ: XRTX) shares moved up 26.89% to $13.26. The volume of Xyratex shares traded was 11058% higher than normal. Seagate Technology Plc (NASDAQ: STX) announced its plans to buy Xyratex for around $374 million in cash.

• [By Patricio Kehoe]

  According to GuruFocus Real Time Picks, on March 7, Mario Gabelli (Trades, Portfolio), the chairman and chief executive officer of GAMCO Investors Inc. added Xyratex Ltd. (XRTX) at an average price of $13.17 and currently holds 742,642 shares of the stock, worth 0.05% of his portfolio.

• [By Rick Aristotle Munarriz]

  Bloomberg via Getty Images You can never know in advance all the news that will move the market in a given week, but some things you can see coming. From a parade of bankers' earnings to a pizza giant rolling out a new crust, here are some of the things that will help shape the week ahead on Wall Street. Monday -- X Marks the Spot: Data storage is a big part of businesses in the modern age; companies have massive amounts of information to manage and keep secure. Xyratex (XRTX) may not be a household name, but it is well-known to corporate IT departments seeking enterprise data storage solutions. Xyratex reports on Monday afternoon. It's seen better days, and analysts predict it will report a sharp drop in revenue. However, Xyratex has been able to beat Wall Street's profit targets with ease over the past four quarters. Tuesday -- Big Banking's Big Close Up: It's going to be a roll call of the "too big to fail" banking behemoths as they step up for their quarterly results. Wells Fargo (WFC) and JPMorgan Chase (JPM) kick things off on Tuesday. That will be followed by Bank of America (BAC) on Wednesday. Citigroup (C) and Goldman Sachs (GS) step up on Thursday. These are interesting times for the financial services providers. Interest rates are starting to move higher, and that may get in the way of demand for mortgages, but it will also help improve the chances that customers open and fund savings and checking accounts. Wednesday -- Tracking Trains: Railroads may seem like yesterday's mode of transportation, but rail remains a viable way to get goods moving across the country. CSX (CSX) reports on Wednesday. The provider of rail, intermodal, and rail-to-truck transload services and solutions has been shipping goods for 185 years. It offers coverage through every major metropolitan market in the eastern United States. Analysts see revenue inching up by 3 percent, with CSX's profit of $0.42 a share besting the $0.40 a share it posted a year earlier. CSX will

Best Building Product Stocks To Watch Right Now: Cheetah Mobile Inc (CMCM)

Cheetah Mobile Inc., formerly Kingsoft Internet Software Holdings Limited, incorporated in July 2009, is a mobile Internet company. For its users, its diversified suite of mission critical applications optimizes Internet and mobile system performance and provides real time protection against known and unknown security threats. For its business partners, its platform provides them multiple user traffic entry points and global content distribution channels capable of delivering targeted content to hundreds of millions of people. The Company��s applications include Clean Master, CM Security, Battery Doctor, Duba Anti-virus, Cheetah Browser and Photo Grid. The Company's core platform products for business partners, such as Duba.com, Cheetah personalized recommendation engine, Game centers, Game centers and Kingmobi mobile advertising network.

The Company��s cloud-based data analytics engines are the core of its platform. For its users, the data analytics engines perform real time analysis of mobile applications, program files and Websites on their devices for behavior that may impair system performance or impose security risks. For its business partners, the data analytics engines help create user interest graphs according to a number of dimensions, such as online shopping, gaming and frequently used applications, thus facilitating targeted content delivery.

Clean Master is a junk file cleaning, memory boosting and privacy protection application. CM Security is an anti-virus and security application for mobile devices on the Android platform. Battery Doctor is a power optimization application. Duba Anti-virus is an Internet security application. Cheetah Browser is its safe Internet browser. Photo Grid is a photo collage application.

The Company competes with Qihoo 360.

Advisors' Opinion:

• [By Steve Symington]

  What:�Shares of Cheetah Mobile (NYSE: CMCM  ) fell 16% Tuesday after the Chinese Internet security software specialist released unaudited first-quarter results.

• [By Garrett Cook]

  Cheetah Mobile (NASDAQ: CMCM) rose 11 percent on news the company had its app relisted in the Google App Store ranking system.  The release was published in a Chinese publication.

• [By Peter Graham]

  Formerly known as Kingsoft Internet Software Holdings Limited, small cap China mobile Internet stock Cheetah Mobile Inc (NYSE: CMCM), a potential peer of other Chinese mobile Internet stocks like NQ Mobile Inc (NYSE: NQ), Qihoo 360 Technology Co Ltd (NYSE: QIHU)�and China Mobile Games and Entertainment Group Limited (NASDAQ: CMGE), is ranked as the ninth most shorted stock on the NYSE with short interest of 38.02% according to Highshortinterest.com.

Best Building Product Stocks To Watch Right Now: Mattress Firm Holding Corp (MFRM)

Mattress Firm Holding Corp. (Mattress Firm), incorporated on January 5, 2007, is a specialty retailer of mattresses and related products and accessories in the United States. The Company conducts its operations through its indirect, wholly owned subsidiary, Mattress Holding Corp. and its subsidiaries. As of August 2, 2011, the Company and its franchisees operated 620 and 107 stores, respectively, primarily under the Mattress Firm name, in 60 markets across 25 states. The Company focuses on the national brands, but also offers its customers its Hampton and Rhodes private label mattresses. The Company has introduced its YuMe brand. On October 15, 2010, the Company acquired Peak Management, LLC. On December 1, 2010, the Company acquired Maggie's Enterprises, Inc. In May 2012, Mattress Firm announced the completion of its acquisition of regional bedding company, Mattress Giant Holding Corp. Effective September 9, 2013, Mattress Firm Holding Corp, a unit of JW Childs Associates LP, acquired Olejo Inc, a provider of ecommerce retail services.

The Company��s stores carry national mattress brands, with a range of styles, sizes, price points and features. The Company provides its customers with their choice of traditional mattresses, including Sealy and Simmons, as well as specialty mattresses, such as Tempur-Pedic. In addition to its mattress selection, the Company offers a range of bedding-related products and accessories.

Conventional Mattresses

Conventional mattresses, such as those of Sealy (including Sealy Posturepedic and Stearns and Foster) and Simmons (including Simmons Beautyrest), utilize steel-coil innersprings. During the fiscal year ended February 1, 2011, the conventional mattresses represented approximately 75% of bedding industry sales in the United States and approximately 60% of the Company��s total sales. In addition to these national brands, the Company also offers its Hampton and Rhodes private label mattresses.

Specialty Mattresses

Specialty mattresses, such as those manufactured by Tempur-Pedic and select comfort, utilize materials other than steel-coil innersprings to provide comfort and support. In fiscal 2010, the specialty mattresses represented approximately 30% of the Company��s total sales. The Company is expanding its assortments in the categories, including viscoelastic foam mattresses and yume sleep system. Viscoelastic foam, also referred to as memory foam or polyurethane foam, features a temperature sensitive foam core that reduces pressure points and tossing and turning by contouring to one's body. The Company has introduced a sleep system made of foam produced from coconut oil, utilizing a technology that uses ambient air to heat and cool the mattress surface.

Furniture and Accessories

During fiscal 2010, the Company was in the process of introducing new headboards and footboards, which complement its current bedding products. All of the Company��s stores carry an assortment of bedding-related accessories, including bed frames, mattress pads and pillows. In fiscal 2010, bedding-related products and accessories represented approximately 7% of the Company��s total sales from Company-operated stores.

The Company competes with Mattress Giant, American Mattress, Haverty's, Rooms-To-Go, Macy's, Sears, JC Penney, Walmart, Costco and Original Mattress.

Advisors' Opinion:

• [By John Kell]

  Mattress Firm Holding Corp.(MFRM) tempered expectations for 2013, as the company said results were hurt by poor winter weather and lower margins tied to efforts to drive sales and traffic during the final quarter of the year. Shares slumped 9.9% to $37.17 premarket.

• [By Rebecca McClay]

  In consumer stocks news, Mattress Firm Holding Corp. (Nasdaq: MFRM) shares are down 15% as the company reported Q2 adjusted earnings per share (EPS) of $0.43 versus consensus estimate of $0.51. Net sales were $302.5 million, compared to the $323 million the Street expected. Year-ago adjusted EPS was $0.42, on net sales of $262 million.

• [By Lisa Levin]

  Mattress Firm Holding (NASDAQ: MFRM) shares reached a new 52-week high of $47.03 after the company reported upbeat Q4 earnings and raised its FY14 forecast.

Best Building Product Stocks To Watch Right Now: Lazard LTD. (LAZ)

Lazard Ltd., together with its subsidiaries, operates as a financial advisory and asset management firm. The company�s Financial Advisory segment offers various advisory services on mergers and acquisitions, and other strategic matters, as well as on restructurings, capital structure, capital raising, and other financial matters. Its Asset Management segment provides investment solutions and investment management services in equity and fixed income strategies; and alternative investments and private equity funds. The company serves corporations, governments, institutions, partnerships, and individual clients. It operates from 42 cities across 27 countries in Europe, North America, Asia, Australia, the Middle East, and Central and South Americas. Lazard Ltd. was founded in 1848 and is based in Hamilton, Bermuda.

Advisors' Opinion:

• [By David Hanson and Matt Koppenheffer]

  In this segment from Thursday's episode of The Motley Fool's everything-financials show,�Where the Money Is, banking analysts Matt Koppenheffer and David Hanson go through a rapid-fire round of three top headlines. The newsmakers included�KKR (NYSE: KKR  ) ,�Bank of America (NYSE: BAC  ) ,�Morgan Stanley (NYSE: MS  ) ,�Lazard (NYSE: LAZ  ) , and�Evercore (NYSE: EVR  ) .

• [By Ben Levisohn]

  Horowitz predicts Lazard (LAZ), which returned 55% last year, to gain just 4% in 2014 as weaker merger & acquisition activity will weight on earnings.

Best Building Product Stocks To Watch Right Now: CannaVEST Corp (CANV)

CannaVEST Corp., formerly Foreclosure Solutions, Inc., incorporated on December 9, 2010, is engaged in the business of developing, producing, marketing and selling end consumer products to the nutriceutical industry containing the hemp plant extract, Cannabidoil (CBD). The Company produces raw ingredients for neutraceutical markets. This substance can be used with foods and nutritional supplements for consumer health and wellness benefits, as well as in the pharmaceutical industry. On March 4, 2013, the Company acquired KannaLife Sciences, Inc. On December 31, 2012, the Company acquired certain assets of PhytoSPHERE Systems, LLC (PhytoSPHERE). It also secured the license to the name PhytoSPHERE and PhytoSPHERE Systems for use in the development and commercialization of hemp-based products.

The Company focuses to develop applicable raw ingredients, and provide raw ingredients for the production and development of multiple existing and developing product applications. Its focus is to produce, market and distribute hemp-based consumer products, as well as acquire existing businesses involved in the industrial hemp industries.

Advisors' Opinion:

• [By John Udovich]

  The Marijuana Index is Really Getting Stoned. The Marijuana Index, which is the first and only registered equity tracking index for marijuana stocks, cannabis stocks and hemp stocks,�experienced significant volume and price fluctuations throughout the month of February when is started the month at the $25 level only to close the month at $56.21 for a 125% gain as some marijuana stocks experienced all time highs. Notable gainers included Abattis Bioceuticals (OTCMKTS: ATTBF)�being up 194%, Advanced Cannabis Solutions (OTCQB: CANN) being up 132% and CannaVest (OTCMKTS: CANV) being up 116%. You can see all of the�Marijuana Index��s advancers and decliners at http://www.marijuanaindex.org.

• [By Dan Burrows]

  But it doesn’t end there. Investors should run away from all OTC marijuana stocks, including Medical Marijuana (MJNA), Cannabis Science (CBIS), CannaVest (CANV), MediSwipe (MWIP) and GreenGro Technologies (GRNH). As the SEC warns:

Best Building Product Stocks To Watch Right Now: Heidrick & Struggles International Inc (HSII)

Heidrick & Struggles International, Inc. (Heidrick & Struggles) is an advisory firm providing executive search and leadership consulting services. As of December 31, 2011, the Company provided its services to a range of clients through the expertise of 347 consultants located in various cities around the world. The Company��s service offerings include executive search, leadership consulting and client base. The Company helps its clients build leadership teams by facilitating the recruitment, management and deployment of senior executives. In addition to executive search, it provides a range of leadership consulting services to clients. These services include succession planning, executive assessment, talent retention management, executive development, transition consulting for newly appointed executives, and mergers and acquisitions human capital integration consulting. In November 2013, Heidrick & Struggles International, Inc announced the acquisition of Scambler MacGregor.

The Company��s clients includes clients include Fortune 1000 companies, non-United States companies, middle market and emerging growth companies, governmental, higher education and not-for-profit organizations and other private and public entities. Heidrick & Struggles provides senior-level executive search and leadership consulting services to its clients worldwide through a network of more than 69 offices in 40 countries. The locations are staffed with consultants, research associates, administrative assistants and other support staff. Administrative functions are centralized where possible, although certain support and research functions are situated regionally because of variations in local requirements.

The Company��s worldwide network includes affiliate relationships in Finland, South Africa, Turkey and Portugal. It has no financial investment in these affiliates but receive licensing fees from them for the use of its name and its databases. Licensing fees are less than 1% of its net revenue. As ! of December 31, 2011, the Company had 160 consultants in its Americas segment, which included New York, Chicago and Atlanta. As of December 31, 2011, the Company had 104 consultants in its European segment, which included the United Kingdom, Germany and France. As of December 31, 2011, the Company had 83 consultants in itsAsia Pacific segment, which included China (including Hong Kong), Australia and Singapore. The Company��s executive search business operates in six broad industry groups: Financial Services, Industrial, Consumer Markets, Global Technology and Services, Life Sciences, and Education and Social Enterprise.

Its executive search consultants also specialize in searches for specific C-level functional positions, which are roles that generally report directly to the chief executive officer. These include chief financial officers, chief information officers, chief legal officers, chief marketing officers and chief human resources officers. The Company��s Global Functional Practices include Chief Executive Officer and Board of Directors; Chief Human Resources Officers; Financial Officers; Information Officers; Interim Executives; Legal, Risk, Compliance & Government Affairs; Marketing, Sales & Strategy Officers; Multicultural & Digital Marketing; Sales Officers; Research & Development; and Supply Chain & Transportation.

The Company competes with Egon Zehnder International, Korn/Ferry International, Russell Reynolds Associates, Inc. and Spencer Stuart & Associates.

Advisors' Opinion:

• [By Anders Bylund]

  And if you thought this crack team would look only at internal promotion candidates, headhunter firm Heidrick & Struggles (NASDAQ: HSII  ) is there to vet the field of outsider candidates. It's a high-profile contract for Heidrick, but the stock fell 0.7% today anyhow. The lack of popping champagne corks in the company's Chicago headquarters is an indication of just how tough this recruitment drive will be.

Best Building Product Stocks To Watch Right Now: Marine Products Corp (MPX)

Marine Products Corporation (Marine Products), incorporated on August 31, 2000, designs, manufactures and sells recreational fiberglass powerboats in the sportboat, deckboat, cruiser, sport yacht and sport fishing markets. The Company sells its products to a network of 135 domestic and 69 international independent authorized dealers. The Company focuses to remain a manufacturer of recreational powerboats for sale to a range of consumers globally. The Company manufactures Chaparral sterndrive and inboard-powered pleasure boats including H2O Sport and Fish & Ski boats, SSi and SSX Sportboats, Sunesta Sportdecks and Xtreme Tow boats, Signature Cruisers, Premiere Sport Yachts and Robalo outboard sport fishing boats. The Company offers a range of products to the family recreational, cruiser and sport yacht markets through its Chaparral brand, and to the sport fishing market through its Robalo brand.

The Company's products include Chaparral - H2O Sport Series, which is a fiberglass multipurpose runabouts; Chaparral - SSi Wide tech, which is a fiberglass closed deck runabouts; Chaparral - SSX Sportdecks, which is a fiberglass bowrider crossover sportboats; Chaparral - Sunesta Xtreme Tow Boats, which is a fiberglass pleasure boats; Chaparral - Signature Cruisers, which is a fiberglass, accommodation-focused cruisers; Chaparral - Premiere Sport Yacht, which is a fiberglass sport yacht, and Robalo - Sport Fishing Boats, which is a sport fishing boats for freshwater lakes or saltwater use. Domestic sales are made through approximately 74 Chaparral dealers, 16 Robalo dealers and 45 dealers that sell both brands located in markets throughout the United States. Marine Products also has 69 international dealers.

The Company competes with Sea Hunt, Sea Fox, Grady-White, Boston Whaler, Everglades and Parker.

Advisors' Opinion:

• [By Sean Williams]

  Sink or swim
  Sometimes the best short-sale opportunities are small, under-the-radar companies. One that I feel fits the bill perfectly is fiberglass boat maker Marine Products (NYSE: MPX  ) .

Best Blue Chip Companies To Watch For 2015

I think the flagship of any portfolio that has a capital appreciation mandate ought to be a superbly run large-cap growth fund. There's no lack of them at Fidelity and my model portfolios reflect what I think are the best of breed in a prize-winning herd, says Jim Lowell, editor of Fidelity Investor.

First, from my perspective, Fidelity's growth funds pursue the following course: Growth and Value really mean the X-factor, wherein managers perceive mispriced value to be had from overlooked earnings growth potential. A broad brush, but it covers the barn and most of the horses inside.

I like large-cap growth, especially with a domestic tilt. In general, it's hard to not pick a winning large-cap growth fund at Fidelity, but it gets a bit trickier when you want the best of the best. Here's some of my buy-rated picks.

Blue Chip Growth (FBGRX)

Manager Sonu Kalra's blue chip bent is what you'd expect. His approach to finding above-average potential for growth in the most analyzed group of stocks on the planet reveals some stellar stock picking. Foreign investments make up 7.3% of the holdings.

Hot Recreation Stocks To Watch Right Now: International Business Machines Corporation(IBM)

International Business Machines Corporation (IBM) provides information technology (IT) products and services worldwide. Its Global Technology Services segment provides IT infrastructure and business process services, including strategic outsourcing, process, integrated technology, and maintenance services, as well as technology-based support services. The company?s Global Business Services segment offers consulting and systems integration, and application management services. Its Software segment offers middleware and operating systems software, such as WebSphere software to integrate and manage business processes; information management software for database and enterprise content management, information integration, data warehousing, business analytics and intelligence, performance management, and predictive analytics; Tivoli software for identity management, data security, storage management, and datacenter automation; Lotus software for collaboration, messaging, and so cial networking; rational software to support software development for IT and embedded systems; business intelligence software, which provides querying and forecasting tools; SPSS predictive analytics software to predict outcomes and act on that insight; and operating systems software. Its Systems and Technology segment provides computing and storage solutions, including servers, disk and tape storage systems and software, point-of-sale retail systems, and microelectronics. The company?s Global Financing segment provides lease and loan financing to end users and internal clients; commercial financing to dealers and remarketers of IT products; and remanufacturing and remarketing services. It serves financial services, public, industrial, distribution, communications, and general business sectors. The company was formerly known as Computing-Tabulating-Recording Co. and changed its name to International Business Machines Corporation in 1924. IBM was founded in 1910 and is based in Armonk, New York.

Advisors' Opinion:

• [By Tim Brugger]

  International Business Machines (NYSE: IBM  ) and Italy-based commercial bank UniCredit have entered into a "multi-billion dollar, 10-year agreement," in which IBM will provide UniCredit with cloud-based infrastructure support throughout Europe, IBM announced today. Financial specifics of the long-term agreement were not disclosed.

• [By WALLSTCHEATSHEET]

  IBM provides essential information technology products and services to growing companies and consumers around the world. The stock has been on a strong bull run in recent years but is now consolidating slightly below all-time high prices. Earnings have been steadily increasing while revenue figures have decreased over the last four quarters, which has confused investors a bit. Relative to its strong peers and sector, IBM has trailed in year-to-date performance. WAIT AND SEE what IBM does this coming quarter.

Best Blue Chip Companies To Watch For 2015: Apple Inc.(AAPL)

Apple Inc., together with subsidiaries, designs, manufactures, and markets personal computers, mobile communication and media devices, and portable digital music players, as well as sells related software, services, peripherals, networking solutions, and third-party digital content and applications worldwide. The company sells its products worldwide through its online stores, retail stores, direct sales force, third-party wholesalers, resellers, and value-added resellers. In addition, it sells third-party Mac, iPhone, iPad, and iPod compatible products, including application software, printers, storage devices, speakers, headphones, and other accessories and peripherals through its online and retail stores; and digital content and applications through the iTunes Store. The company sells its products to consumer, small and mid-sized business, education, enterprise, government, and creative markets. As of September 25, 2010, it had 317 retail stores, including 233 stores in the United States and 84 stores internationally. The company, formerly known as Apple Computer, Inc., was founded in 1976 and is headquartered in Cupertino, California.

Advisors' Opinion:

• [By Doug Ehrman]

  Apple (NASDAQ: AAPL  ) and�Google (NASDAQ: GOOG  ) �compete with each other over nearly every aspect of smartphone operations and ecosystems. One arena in which Cupertino may be winning the battle is fragmentation. A recent story from AllThingsD�highlights that while Apple does a great job of keeping users of iOS�on the most current generation, Android users are "trapped" on multiple -- often dated -- versions. This manifests in the relative appeal of each OS for developers, which continues to draw them toward Apple.

Best Blue Chip Companies To Watch For 2015: McDonald's Corporation(MCD)

McDonald?s Corporation, together with its subsidiaries, operates as a worldwide foodservice retailer. It franchises and operates McDonald?s restaurants that offer various food items, soft drinks, coffee, and other beverages. As of December 31, 2009, the company operated 32,478 restaurants in 117 countries, of which 26,216 were operated by franchisees; and 6,262 were operated by the company. McDonald?s Corporation was founded in 1948 and is based in Oak Brook, Illinois.

Advisors' Opinion:

• [By Kyle Spencer]

  McDonald's (MCD) is slashing its 20 piece box from 36 to 20 RMB "��灏�涓���. Given the 4% higher comp rate that McDonald's is already being punished with as it tries to adjust to Asian palates, how badly do you think McDonald's Asian sales are going to suffer if they can't sell chicken?

• [By Jim Royal]

  Let's take McDonald's (NYSE: MCD  ) as an example. In the four quarters ending in December, the restaurateur generated $6.97 billion in operating cash flow. It invested about $3.05 billion in property, plant, and equipment. To calculate free cash flow, subtract McDonald's investment from its operating cash flow. That leaves us with $3.92 billion in free cash flow, which the company can save for future expenditures or distribute to shareholders.

• [By Rich Duprey]

  Flipping burgers
  So when you first hear about employees attending McDonald's (NYSE: MCD  ) Hamburger University or Starbucks staffers taking Barista Basics courses and earning college credits for it, you'd be forgiven for thinking they're the educational equivalent of cotton candy: a fun snack but hardly fulfilling.

• [By Jonas Elmerraji]

  Switching gears outside of the energy sector brings us to fast food chain McDonald's (MCD), another name on hedge funds' hate list. McDonald's has had a pretty tepid year in 2014, down 2.6% over a stretch when the S&P is within grabbing distance of double-digit upside. So it's not hugely surprising that fund managers don't have the patience to stick it out with MCD this fall. Funds sold 2.29 million shares of McDonald's over the course of the third quarter...

  McDonald's is the biggest fast food restaurant chain in the world, with approximately 35,900 restaurant locations in 125 countries. Of those, nearly 7,000 are company-owned units. The other 80% of stores are franchised. That model has been a cash cow for MCD shareholders in the past, giving the firm claim to sticky recurring revenues supplying franchise stores with food ingredients, marketing, and employee training. Importantly, McDonald's owns the land beneath the majority of its franchisee restaurants; that huge land portfolio gives McDonald's more in common with a REIT than with the diner down the street.

  The competitive nature of the fast food business means that MCD has gotten the squeeze in recent quarters as it tries to play catch up with a consumer that's moving up the "food chain" (so to speak) -- an ongoing initiative to improve food quality and make MCD more nimble should pay dividends down the road. In the meantime, McDonald's continues to execute well, especially given the discount currently on shares versus six months ago. The firm's 3.6% dividend yield should add some extra attractiveness given the prolonged low-interest rate environment that's expected to stretch well into 2015.

  It looks like funds are making a mistake by selling MCD early here...

Best Blue Chip Companies To Watch For 2015: Colgate-Palmolive Company(CL)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and markets consumer products worldwide. It offers oral care products, including toothpaste, toothbrushes, and mouth rinses, as well as dental floss and pharmaceutical products for dentists and other oral health professionals; personal care products, such as liquid hand soap, shower gels, bar soaps, deodorants, antiperspirants, shampoos, and conditioners; and home care products comprising laundry and dishwashing detergents, fabric conditioners, household cleaners, bleaches, dishwashing liquids, and oil soaps. The company offers its oral, personal, and home care products under the Colgate Total, Colgate Max Fresh, Colgate 360 Advisors' Opinion:

• [By TaniaC]

  Colgate-Palmolive Company (CL) is a consumer products company whose products are marketed in over 200 countries and territories throughout the world. It operates in two segments: Oral, Personal and Home Care and Pet Nutrition.

Best Blue Chip Companies To Watch For 2015: Chevron Corporation(CVX)

Chevron Corporation, through its subsidiaries, engages in petroleum, chemicals, mining, power generation, and energy operations worldwide. It operates in two segments, Upstream and Downstream. The Upstream segment involves in the exploration, development, and production of crude oil and natural gas; processing, liquefaction, transportation, and regasification associated with liquefied natural gas; transportation of crude oil through pipelines; and transportation, storage, and marketing of natural gas, as well as holds interest in a gas-to-liquids project. The Downstream segment engages in the refining of crude oil into petroleum products; marketing of crude oil and refined products primarily under the Chevron, Texaco, and Caltex brand names; transportation of crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car; and manufacture and marketing of commodity petrochemicals, plastics for industrial uses, and fuel and lubricant additives. It a lso produces and markets coal and molybdenum; and holds interests in 13 power assets with a total operating capacity of approximately 3,100 megawatts, as well as involves in cash management and debt financing activities, insurance operations, real estate activities, energy services, and alternative fuels and technology business. Chevron Corporation has a joint venture agreement with China National Petroleum Corporation. The company was formerly known as ChevronTexaco Corp. and changed its name to Chevron Corporation in May 2005. Chevron Corporation was founded in 1879 and is based in San Ramon, California.

Advisors' Opinion:

• [By Maxx Chatsko]

  Its citizens may drive on the "wrong" side of the road, but Australia is set to become the driving force for Chevron (NYSE: CVX  ) stock. America's third largest company has joined industry peers to pour close to $100 billion into developing its oil and natural gas fields. And for good reason. Australia represents the biggest immediate growth opportunity for the energy industry. It only gets bigger when you consider that its proximity to the Asian market provides an easy destination for liquefied natural gas, or LNG, and big profits. Chevron's leadership position will allow it to reap the biggest rewards.

• [By Matt DiLallo]

  ExxonMobil has been struggling to grow its production in a meaningful way for a few years now. However, on a per-share basis, the company's production growth has been industry leading, thanks to its steady buybacks. Over the past five years, each share has an interest in 21% more production, which is an annualized growth rate per share of 5%. As the following chart shows, ExxonMobil easily outpaces Chevron (NYSE: CVX  ) , Royal Dutch Shell (NYSE: RDS-A  ) and BP (NYSE: BP  ) :

Top 10 International Stocks To Invest In 2015

The Department of Defense awarded Philips (NYSE: PHG  ) Healthcare Informatics an $88.5 million-ceiling value, firm-fixed-price contract for the supply of a digital imaging network-picture archive�system. In so doing, it made progress on a project that's been in the works for 16 years.

In 1997, the DoD first issued requirements for what was then designated the "Digital Imaging Network-Picture Archiving and Communications System." At the time, DIN-PACS was described as "an open systems network of digital devices designed for the effective acquisition, transmission, display and management of diagnostic imaging studies." In essence, it would digitize X-Ray and MRI scans and put them in a form that could be easily transmitted from doctor-to-doctor electronically. DIN-PACS would be made interoperable with not just civilian hospitals in the U.S., but designed based on two truly international standards, Digital Imaging and Communications in Medicine (DICOM) and Health Level 7 (HL7).

Top Freight Companies For 2016: Roper Industries Inc.(ROP)

Roper Industries, Inc. designs, manufactures, and distributes radio frequency (RF) products and services, industrial technology products, energy systems and controls, and medical and scientific imaging products and software. Its Medical and Scientific Imaging segment offers patient positioning devices, 3-D measurement technology, diagnostic and therapeutic disposable products, ultrasound bladder volume measurement instruments, and video laryngoscopes; digital imaging products and software; and handheld and vehicle mount computers and software. The company?s Energy Systems and Controls segment produces control systems, fluid properties testing equipment, industrial valves and controls, sensors and controls, and non-destructive inspection and measurement products and solutions. Its Industrial Technology segment produces water and fluid handling pumps, equipment and consumables, leak testing equipment, flow measurement and metering equipment, water meter, and automatic meter reading products and systems. The company?s RF Technology segment provides radio frequency identification communication technology and software solutions that are used in toll and traffic systems and processing; security and access control; campus card systems; software-as-a-service in the freight matching and food industries; and metering and remote monitoring applications. It markets its products to RF applications, medical, water, energy, research, education, software-as-a-service-based information networks, and security markets. The company distributes its products through direct sales personnel, manufacturers? representatives, value added resellers, original equipment manufacturers, and distributors. It principally operates in the United States, Canada, Asia, Europe, the Middle East, and South America. Roper Industries, Inc. was founded in 1981 and is based in Sarasota, Florida.

Advisors' Opinion:

• [By Rich Duprey]

  It's a bit incongruous, but industrial manufacturing specialist Roper� (NYSE: ROP  ) is now the proud owner of Managed Health Care Associates, a New Jersey-based supplier of services for�alternate site health-care providers.�The transaction was valued at approximately $1 billion, and was funded from Roper's�available cash and borrowings under its credit facility.

• [By Marc Bastow]

  Radio frequency products manufacturer and distributor Roper (ROP) raised its quarterly dividend 21% to 20 cents per share, payable on Jan. 14 to shareholders of record as of Jan. 10. This marks the 21st consecutive rise in Roper’s annual dividend.
  ROP Dividend Yield: 0.6%

• [By Lauren Pollock]

  Among the companies with shares expected to actively trade in Monday’s session are Merck(MRK) & Co., Biogen Idec Inc.(BIIB) and Roper Industries Inc.(ROP)

Top 10 International Stocks To Invest In 2015: Lightstream Resources Ltd (LSTMF.PK)

Lightstream Resources Ltd, formerly PetroBakken Energy Ltd., is a Canada-based oil and gas exploration and production company. The Company�� principal operating areas include southeastern Saskatchewan where it targets the Bakken formation and conventional Mississippian reservoirs, central Alberta, where it is focused on the Cardium formation, and north-central Alberta, where it is engaged in exploring for light oil resource plays. In addition, the Company also has land holdings in the Horn River and Montney plays in northeast British Columbia. On December 31, 2012, Petrobank Energy and Resources Ltd. and PetroBakken Energy Ltd. announced the completion of the reorganization. The Reorganization resulted in a newly incorporated company PetroBakken Energy Ltd. (New PetroBakken). Advisors' Opinion:

• [By MLP Trader]

  Here are the current top five companies in the list:

  CompanySymbolEV/BOEPD/NetbackPrice/NAVEV/DACFPinecrest(PNCGF.PK)53564%4.0XLightstream(LSTMF.PK)131753%4.5XNovus(NOVUF.PK)133290%4.1XZargon(ZARFF.PK)138664%5.6XTwin Butte(TBTEF.PK)155885%5.5X

  Of the larger companies, one that remains obstinately near the top of the list is Lightstream . Lightstream trades at 40% of its book value and a whopping 13.4% yield.

Top 10 International Stocks To Invest In 2015: Micron Technology Inc.(MU)

Micron Technology, Inc., together with its subsidiaries, engages in the manufacture and marketing of semiconductor devices worldwide. Its products include dynamic random access memory (DRAM) products that provide data storage and retrieval, which include DDR2 and DDR3; and other specialty DRAM memory products, including DDR, SDRAM, DDR and DDR2 mobile low power DRAM, pseudo-static RAM, and reduced latency DRAM. The company also offers NAND flash memory products, which are electrically re-writeable and non-volatile semiconductor devices that retain content when power is turned off. In addition, it provides NOR flash memory products that are electrically re-writeable and non-volatile semiconductor memory devices; phase change memory products; and image sensor products. Micron Technology?s products are used in a range of electronic applications, including personal computers, workstations, network servers, mobile phones, flash memory cards, USB storage devices, digital still c ameras, MP3/4 players, and in automotive applications. It sells its products to original equipment manufacturers and retailers through internal sales force, independent sales representatives, and distributors, as well as through a Web-based customer direct sales channel. The company was founded in 1978 and is headquartered in Boise, Idaho.

Advisors' Opinion:

• [By Jonas Elmerraji]

  As impressive as T-Mobile's rally has been in 2013, it doesn't hold a candle to the momentum in shares of Micron Technology (MU) this year: since the calendar flipped over to January, Micron's share price has exploded by 207%. And with the way this stock is positioned right now, it's not too late to take the reins in Micron.

  Micron is a computer memory maker that until recently was best known for manufacturing RAM for PCs. But the company has spent the last several years building its flash memory business, a switch that exposes Micron to a far more lucrative niche. Flash memory is a supply constrained business -- it's costly for newcomers to try to ramp up production, and the surge mobile device purchases has driven demand for NAND flash memory through the roof. That's helped Micron collect heftier prices and deeper margins for its efforts.

  Most of Micron's flash memory customers are original equipment manufacturers, not consumers. Those OEM connections are a big advantage because they keep sales efforts minimal. Instead, the firm just needs to keep creating flash technology that device makers want. The increasing use of flash memory in enterprise settings (such as servers) is another big trend that's helped to propel Micron's share price in 2013.

• [By Paul Ausick]

  We have tracked the key short interest changes as of September 30 in the following semiconductor leaders: Intel Corp. (NASDAQ: INTC), Advanced Micro Devices Inc. (NYSE: AMD), Micron Technology Inc. (NASDAQ: MU), SanDisk Corp. (NASDAQ: SNDK), Qualcomm Inc. (NASDAQ: QCOM), ARM Holdings PLC (NASDAQ: ARMH), Broadcom Corp. (NASDAQ: BRCM), Marvell Technology Group Ltd. (NASDAQ: MRVL), Nvidia Corp. (NASDAQ: NVDA), Texas Instruments Inc. (NASDAQ: TXN) and Applied Materials Inc. (NASDAQ: AMAT). We also chose to look at how the Market Vectors Semiconductor ETF (NYSEMKT: SMH) has held up.

Top 10 International Stocks To Invest In 2015: ChemoCentryx Inc (CCXI)

ChemoCentryx is a biopharmaceutical company focused on discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer. The Company targets the chemokine system, a network of molecules, including chemokine ligands and their associated receptors, as well as related chemo-attractant receptors, all of which are known to drive inflammation. As of December 31, 2011, the Company had four drug candidates in clinical development. Its drug candidates include Traficet-EN (CCX282, GSK'786 or vercirnon), CCX140, CCX354, CCX168, CCX872, CCX507 and CCX662. The Company is also advancing several additional independent drug candidates through preclinical development. The Company�� wholly owned subsidiary is ChemoCentryx Limited.

The Company's drug candidate Traficet-EN (CCX282, GSK'786), is to control the inflammatory response underlying IBD by targeting the chemokine receptor known as CCR9. The Company has completed nine clinical trials with Traficet-EN in a total of 785 subjects, including five Phase I clinical trials (three in the United States and two in the United Kingdom), one thorough QT study in the United States (an assessment of cardiovascular safety which is required for regulatory approval), and three Phase II clinical trials (one in the Netherlands, the United Kingdom, and the United States, one in Finland and one (PROTECT-1) in Australia, Austria, Belgium, Brazil, Bulgaria, Canada, the Czech Republic, Denmark, France, Germany, Hungary, Israel, the Netherlands, Poland, South Africa, Sweden and the United Kingdom). As of December 31, 2011, the Company�� Traficet-EN drug candidate is in four pivotal Phase III clinical trials being conducted by its partner Glaxo Group Limited (GSK).

The Company's independent drug candidate CCX140, targets the chemokine receptor known as CCR2. CCX140 is a potent and selective antagonist of CCR2 that is found on subsets of monocytes and macrophages, which are cells of th! e immune system. In January 2011, the Company completed a 159-patient randomized Phase II clinical trial, conducted in Australia, the Czech Republic, Germany, Hungary and New Zealand, to assess the safety and tolerability of CCX140 in patients with type 2 diabetes. In addition, CCX140 demonstrated biological activity through a dose-dependent decrease in fasting plasma glucose.

CCX354 targets the chemokine receptor known as CCR1. Synovial fluid from the joints of rheumatoid arthritis (RA) patients contains high levels of activated CCR1 chemokine ligands. The Company completed two Phase I clinical trials in a total of 84 healthy subjects, conducted in Switzerland followed by a Phase I/II clinical trial in 24 patients with stable RA, conducted in Belgium and Romania, and a Phase II proof-of-concept clinical trial in 160 patients with moderate-to-severe RA, conducted in Belgium, the Czech Republic, Germany, Hungary, Poland, Romania and the Ukraine. GSK exercised its option to further develop and commercialize CCX354 in November 2011 and had an exclusive right to initiate a Phase II b clinical trial for CCX354 in RA.

CCX168 targets the chemo-attractant C5a receptor (C5aR), which binds to a biologically activated fragment of the complement protein known as C5. As of December 31, the Company completed a Phase I clinical trial for CCX168, conducted in Switzerland. The Company initiated a Phase II proof-of-concept clinical trial in AAV in the fourth quarter of 2011. Its CCX872 is an independent next generation CCR2 drug candidate for the treatment of metabolic diseases, its CCX507 is an independent drug candidate for the treatment of inflammatory bowel disease (IBD) and CCX662 is an independent drug candidate for the treatment of glioblastoma multiforme (GBM).

The Company competes with Abbott Laboratories, Amgen Inc, AstraZeneca plc, Biogen Idec Inc, Bayer AG, Elan Corporation plc, Glaxo Group Limited, Merck & Co Inc, Merck Serono, Takeda Pharmaceutical Co Ltd, Novartis AG! , Pfizer ! Inc, Reata Pharmaceuticals, Inc., Sanofi SA, Teva Pharmaceutical Industries Ltd, Bristol-Myers Squibb, Incyte Corp and UCB Pharma.

Advisors' Opinion:

• [By CRWE]

  ChemoCentryx, Inc. (Nasdaq:CCXI), reported that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will present at the BioCentury NewsMakers in the Biotech Industry Conference on Friday, September 7, 2012, at 9:30 a.m. Eastern Time at the Millennium Broadway Hotel & Conference Center in New York, NY.

Top 10 International Stocks To Invest In 2015: James Hardie Industries SE (JHX)

James Hardie Industries plc, together with its subsidiaries, manufactures and sells fiber cement products and systems for interior and exterior building construction applications primarily in the United States, Canada, Australia, New Zealand, the Philippines, and Europe. Its products principally include fiber cement interior linings, exterior siding products, and related accessories products. The company offers fiber cement products with various patterned profiles and surface finishes for a range of applications, including external siding and soffit lining, internal linings, facades, floor and tile underlay, lattice, fencing, decorative columns, flooring, and ceiling applications; and manufactures and sells fiber reinforced concrete pipes. Its products are used in various markets, such as new residential construction, which include single and multi-family housing; manufactured housing that comprise mobile and pre-fabricated homes; repair and remodeling; and various commerc ial and industrial applications, such as stores, warehouses, offices, hotels, motels, schools, libraries, museums, dormitories, hospitals, detention facilities, religious buildings, and gymnasiums. The company markets its fiber cement products and systems under various Hardie brand names, such as HardieBacker; and other brand names, such as Artisan Lap and Artisan Accent Trim by James Hardie, Cemplank and Prevail siding, Scyon, and Stria siding. The company sells its products directly, as well as through distributors, large home center retailers, small to medium size dealer outlets, and specialist distributors to dealers or lumber yards, consumers, builders, real estate developers, and distributor/hardware stores. James Hardie Industries plc was founded in 1888 and is headquartered in Dublin, the Republic of Ireland.

Advisors' Opinion:

• [By Ian Sayson]

  Exporters dropped. Samsung Electronics slipped 2.9 percent to 1.329 million won in Seoul. Canon Inc., the world�� biggest camera maker, fell 1.1 percent to 3,215 yen in Tokyo. James Hardie Industries SE (JHX), a building materials supplier that gets about 70 percent of sales from the U.S., tumbled 2.8 percent to A$9.37 in Sydney.

Top 10 International Stocks To Invest In 2015: IMS Health Holdings Inc (IMS)

IMS Health Holdings, Inc., incorporated on October 23, 2009, is a global information and technology services company providing clients in the healthcare industry with comprehensive solutions to measure and improve their performance. It has collections of healthcare information in the world, spanning sales, prescription and promotional data, medical claims, electronic medical records and social media. Its scaled and data set, containing over 10 petabytes of data, includes over 85% of the world�� prescriptions by sales revenue and approximately 400 million comprehensive, longitudinal, anonymous patient records. It serves healthcare organizations and decision makers around the world, spanning the breadth of life science companies, including pharmaceutical, biotechnology, consumer health and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers and the financial community.

The Company uses healthcare-specific global information technology (IT) infrastructure to process data from over 45 billion healthcare transactions annually and to collect data from over 780,000 fragmented feeds globally, which it organize in a structured fashion using methodologies. Its intelligent cloud, IMS One opens its global IT infrastructure to its clients and provides the ability to perform business analytics in the cloud with large amounts of complex data. Its principal offerings include National information offerings; Sub-national information offerings; Commercial services; Real-World Evidence (RWE) solutions; Commercial technology solutions, and Clinical solutions.

The Company�� national offerings includes services in more than 70 countries that provide consistent country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment and promotional activity across multiple channels including retail, hospital and mail order. Its sub-national offerings includes services in more than 50 ! countries that provide a consistent measurement of sales or prescribing activity at the regional, zip code and individual prescriber level. The Company provides a set of strategic, analytic and support services to help the commercial operations of life sciences companies transform their commercial models. It integrate information from medical claims, prescriptions, electronic medical records, biomarkers and government statistics into anonymous, longitudinal patient journeys that provide detailed views of treatment patterns, disease progression, therapeutic switching and concomitant diseases and treatments.

The Company provides a range of hosted and cloud-based applications and associated implementation services. The applications, hosted on IMS One, support a range of commercial processes including multi-channel marketing, customer relationship management (CRM), performance management, incentive compensation, territory alignment, roster management and call planning. It helps life sciences companies design and execute clinical trials, and for payers and providers, it enables risk-sharing, pay-for-performance and population health management.

Advisors' Opinion:

• [By Jayson Derrick]

  After pricing its IPO at $20, shares of IMS Health (NYSE: IMS) began trading for the first time at $22.18, traded as high as $23.69 before closing the day at $23.00, up 15.00 percent.

• [By MONEYMORNING.COM]

  Now then, as much as we like several companies in this space, we think investors would do well to take a close look at IMS Health Holdings Inc. (NYSE: IMS).

• [By Jake L'Ecuyer]

  IMS Health Holdings (NYSE: IMS) shares were also up, gaining 17.40 percent to $23.45 in their debut on the NYSE.

  Equities Trading DOWN
  Shares of Halozyme Therapeutics (NASDAQ: HALO) were down 25.40 percent to $8.65 after the company announced the temporary halt of Phase 2 trial enrollment.

Top 10 International Stocks To Invest In 2015: MFS Special Value Trust (MFV)

MFS Special Value Trust (the fund) is a closed-end fund and maintains a portfolio that includes investments in fixed income and equity securities. During the fiscal year ended October 31, 2007, the MFS Special Value Trust provided a total return of 5.11%, at net asset value. The fund's investment objective is to seek high current income, but may also consider capital appreciation.

MFS Special Value Trust normally invests the fund's assets primarily in debt instruments. MFS Special Value Trust normally invests the fund's assets in United States Government securities, foreign government securities, mortgage backed and other asset-backed securities of United States and foreign issuers, corporate bonds of United States and foreign issuers, debt instruments of issuers located in emerging market countries, and equity securities. MFS Special Value Trust�� investment advisor is Massachusetts Financial Services Company.

Advisors' Opinion:

• [By Dividends4Life]

  According to a Gabelli Funds report, managed distribution policies offer several advantages, including:1. Lower difference between the fund�� market price and its NAV per share.2. Provides support during periods when the stock market is in a decline.3. Provides a measurable performance target for the investment adviser.Below are several high-yield funds from CEFA that have a managed distribution policy (yields as of December 16):Aberdeen Australia Eqty (IAF)- Distribution Yield: 10.4%- Income Yield: 3.46%Bexil Advisers LLC� (DNI)- Distribution Yield: 11.1%- Income Yield: 3.56%BlackRock En Capital&Inc (CII)- Distribution Yield: 8.78%- Income Yield: 2.34%Cornerstone Strat Value (CLM)- Distribution Yield: 18.77%- Income Yield: 1.83%Cornerstone Total Return (CRF)- Distribution Yield: 19.10%- Income Yield: 0.85%Delaware Inv Div & Inc (DDF)- Distribution Yield: 6.70%- Income Yield: 5.26%Gabelli Equity Trust (GAB)- Distribution Yield: 7.58%- Income Yield: 1.54%Gabelli Utility Trust (GUT)- Distribution Yield: 9.45%- Income Yield: 2.84%MFS Special Value Trust (MFV)- Distribution Yield: 9.60%- Income Yield: 5.73%Nuveen Tx-Adv TR Strat (JTA)- Distribution Yield: 6.70%- Income Yield: 3.12%TCW Strategic Income (TSI)- Distribution Yield: 10.54%- Income Yield: 7.88%Zweig Total Return (ZTR)- Distribution Yield: 7.27%- Income Yield: 1.95%As noted in the Gabelli report, a managed distribution policy may create confusion regarding the true current yield since the reported yield includes the return of capital portion. You can see the disparity above between the income yield and the distribution (reported) yield.If you are looking for a sustainable and growing dividend, you may want to consider some blue-chip dividend stocks such as these with a Free Cash Flow Payout less than 50%, 50+ years of consecutive dividend increases and a 2%+ yield:3M Co. (MMM) is a diversified global company provides enhanced product functionality in electronics, health care, industrial, consumer

Top Valued Stocks To Buy For 2015

David Fried, editor of the Buyback Letter, explains how he builds portfolios based solely on companies undergoing buyback programs, and highlights some favorite buyback bets for investors.

Steve Halpern: We're here today with David Fried, editor of the Buyback Letter. How are you doing, David?

David Fried: I'm doing well, thank you. How are you doing?

Steve Halpern: Very good. For those who aren't familiar with buybacks, could you explain a little about your interest in this area, how you got involved, and what impact that buyback has on a stock.

David Fried: Sure. Well, there's been a lot of research done on buybacks and companies typically will buy back stock when it's undervalued.

Now, it may be undervalued given an absolute outlook, or it may be undervalued given the future of what's going on with the company, and, of course, the insiders at the company have a bird's eye view for that.

We really consider the ultimate to be insider buying, because the whole Board of Directors and management, pretty much, has to be on board to agree and spend company funds to buy back shares.

Top 10 Cheap Companies To Buy Right Now: Dollar Tree Inc.(DLTR)

Dollar Tree, Inc. operates discount variety stores in the United States and Canada. Its stores offer merchandise primarily at the fixed price of $1.00. The company operates its stores under the names of Dollar Tree, Deal$, Dollar Tree Deal$, Dollar Giant, and Dollar Bills. Its stores offer consumable merchandise, including candy and food, and health and beauty care, as well as household consumables, such as paper, plastics, household chemicals, in select stores, and frozen and refrigerated food; variety merchandise, which includes toys, durable housewares, gifts, party goods, greeting cards, softlines, and other items; and seasonal goods, such as Easter, Halloween, and Christmas merchandise. As of April 30, 2011, it operated 4,089 stores in 48 states and the District of Columbia, as well as 88 stores in Canada. The company was founded in 1986 and is based in Chesapeake, Virginia.

Advisors' Opinion:

• [By WWW.DAILYFINANCE.COM]

  Richard Levine/Alamy These aren't the best of times for discount retailers, but it certainly seems as if Family Dollar (FDO) has become the belle of the marked-down ball. Two chains catering to thrifty-minded shoppers have entered into an unlikely bidding war for Family Dollar, and it's shaping up to be a bit more interesting than your typical love triangle between three retailers with the name "Dollar" in their monikers. The story began late last month when Family Dollar announced that it would be acquired by Dollar Tree (DLTR) in an $8.5 billion transaction. It seemed like a simple enough transaction. Dollar Tree would be paying a reasonable 22 percent premium for Family Dollar. The deal would create a discounting behemoth with 13,000 stores across North America. The combined companies would eventually result in trimming $300 million in annual overhead. It seemed like a great way out for frustrated Family Dollar shareholders. The deep discounter had missed Wall Street's profit targets for three consecutive quarters. Analysts see declining profitability on flat sales for its fiscal year that ends this week. It seemed as if Dollar Tree would have Family Dollar all to itself, but then it got some unexpected company. Turning Down a Fistful of Dollars Dollar General (DG) stepped into the picture last week, offering to pay even more for Family Dollar. It offered an all-cash deal valued closer to $9 billion. The deal seemed to be clearly superior on the surface, but Family Dollar's board shot it down. This wouldn't be the first time that a board sided with a friendly buyout offer to a higher hostile one. Arranged deals often mean cushier positions for the acquired company. However, there was a method to the board's madness this time. Family Dollar declined Dollar General's offer because it felt that antitrust regulators wouldn't let that particular buyout go through. Dollar General rings up more than twice as much in sales as Dollar Tree. The bigger the riv

• [By Aaron Smith]

  Dollar General said the deal is superior to the $74.50 per share cash and stock offer Dollar Tree (DLTR)made last month. That deal has been valued at $8.5 billion.

• [By Ted Cooper]

  Family Dollar (NYSE: FDO  ) reported sales growth even as earnings per share fell amid a tough operating environment and ongoing merger preparations. The company expects to close on a takeover offer proposed by Dollar Tree (NASDAQ: DLTR  ) within the next few quarters. The merger-related restructuring charges and fees hurt the company's bottom line, but earnings fell even after adding back those expenses. Here's what it could mean for shareholders.

• [By Rich Duprey]

  Suburban sprawl
  With more than 8,200 locations stretched across 46 states, Family Dollar is the second-largest dollar store chain, behind industry leader Dollar General (NYSE: DG  ) , which boasts more than 11,300 stores, and firmly ahead of No. 3 player Dollar Tree's (NASDAQ: DLTR  ) �5,100 stores.

Top Valued Stocks To Buy For 2015: Schlumberger N.V.(SLB)

Schlumberger Limited, together with its subsidiaries, supplies technology, integrated project management, and information solutions to the oil and gas exploration and production industries worldwide. The company?s Oilfield Services segment provides exploration and production services; wireline technology that offers open-hole and cased-hole services; supplies engineering support, directional-drilling, measurement-while-drilling, and logging-while-drilling services; and testing services. This segment also offers well services; supplies well completion services and equipment; artificial lift; data and consulting services; geo services; and information solutions, such as consulting, software, information management system, and IT infrastructure services that support oil and gas industry. Its WesternGeco segment provides reservoir imaging, monitoring, and development services; and operates data processing centers and multiclient seismic library. This segment also offers variou s services include 3D and time-lapse (4D) seismic surveys to multi-component surveys for delineating prospects and reservoir management. The company?s M-I SWACO segment supplies drilling fluid systems to improve drilling performance; fluid systems and specialty tools to optimize wellbore productivity; production technology solutions to maximize production rates; and environmental solutions that manages waste volumes generated in drilling and production operations. Its Smith Oilfield segment designs, manufactures, and markets drill bits and borehole enlargement tools; and supplies drilling tools and services, tubular, completion services, and other related downhole solutions. The company?s Distribution segment markets pipes, valves, and fittings, as well as mill, safety, and other maintenance products. This segment also provides warehouse management, vendor integration, and inventory management services. Schlumberger Limited was founded in 1927 and is based in Houston, Texas.

Advisors' Opinion:

• [By David Smith]

  It's now two to one among the big oil-field services companies regarding the North American oil and gas markets. Through Monday, Schlumberger (NYSE: SLB  ) , the largest company in the sector had expressed concern about the market and its short-term prospects, while Halliburton (NYSE: HAL  ) , the second-biggest member of the group, joined Baker Hughes (NYSE: BHI  ) in assessing our continent's activity levels more positively.

• [By Monica Gerson]

  Schlumberger (NYSE: SLB) is expected to report its Q1 earnings at $1.20 per share on revenue of $11.49 billion.

  Danaher (NYSE: DHR) is estimated to report its Q2 earnings at $0.96 per share.

• [By David Smith]

  I noted in Part 1 that Schlumberger (NYSE: SLB  ) , easily the largest participant in the oilfield services space, is appropriate for subsea investing. The same can be said of seismic. The company's WesternGeco unit leaves its competition in the dust -- or water -- from the perspective of both size and technological sophistication.

• [By Vanina Egea]

  To explore and produce, a great investment is required in tools, and one of the leading equipment suppliers is Schlumberger (SLB). A key to remaining on top of the industry is innovation, and of that the company has a whole load. Throughout 2014 alone, the firm has introduced a microseismic surface acquisition system, a new fracturing technique for unconventional reserves, launched a degradable alloy technology to improve well productivity, a multilayer bed boundary detection service for clastic and carbonate fields, and a rotary steerable system that increases directional control and drilling efficiency. These product introductions have been done during the first quarter of 2014, making a strong statement about the company�� research and development pipeline. Gurus, however, mostly dropped the stock during the end of 2013. Let us see whether you can take advantage of the dumping and take a large position with long-term prospects.

Top Valued Stocks To Buy For 2015: Tupperware Corporation(TUP)

Tupperware Brands Corporation operates as a direct seller of various products across a range of brands and categories through an independent sales force. The company engages in the manufacture and sale of kitchen and home products, and beauty and personal care products. It offers preparation, storage, and serving solutions for the kitchen and home, as well as kitchen cookware and tools, children?s educational toys, microwave products, and gifts under the Tupperware brand name primarily in Europe, Africa, the Middle East, the Asia Pacific, and North America. The company provides beauty and personal care products, which include skin care products, cosmetics, bath and body care, toiletries, fragrances, nutritional products, apparel, and related products principally in Mexico, South Africa, the Philippines, Australia, and Uruguay. It offers beauty and personal care products under the Armand Dupree, Avroy Shlain, BeautiControl, Fuller, NaturCare, Nutrimetics, Nuvo, and Swissgar de brand names. The company sells its Tupperware products directly to distributors, directors, managers, and dealers; and beauty products primarily through consultants and directors. As of December 26, 2009, the Tupperware distribution system had approximately 1,800 distributors, 61,300 managers, and 1.3 million dealers; and the sales force representing the Beauty businesses approximately 1.1 million. The company was formerly known as Tupperware Corporation and changed its name to Tupperware Brands Corporation in December 2005. The company was founded in 1996 and is headquartered in Orlando, Florida.

Advisors' Opinion:

• [By Jonathan Berr]

  Multilevel marketing (MLM) groups such as Herbalife operate through independent sales representatives, who earn money both through the sales of product and by recruiting other people to join their team. This business model — which is used by scores of companies, including�Pampered Chef, which is owned by Warren Buffett’s Berkshire Hathaway (BRK.B), Tupperware (TUP) and Mary Kay Cosmetics — is legal provided that actual products are sold.

• [By Teresa Rivas]

  We think KMB will be perceived as the safest of the multinationals. Its sales outside the US are about 55% of total; this compares to 65%-70% for Procter & Gamble (PG) and Coty (COTY) and 80%-90% for Colgate (CL), Avon and Tupperware (TUP). In general, its risk to the most volatile currencies is below average (its exposure to Eastern Europe is less than 2% of sales), though it is still translating results in Venezuela (about 3% of sales and profit) at the official rate of 6.3 VEF/$ (the parallel rate just hit 175 VEF/$) and Argentina (also 3% of sales) may devalue again. The cost of important raw materials has started to weaken; as they follow oil�� decline they could boost gross margins in 2H15. Of note, polypropylene and natural gas are off 17% 4Q-to-date; pulp prices, while not declining much, seem manageable.

• [By Ben Levisohn]

  Shares of Herbalife have gained 0.9% to $79.51 this morning in pre-open trading. Its shares have gained 139% this year, a nice gain, but lagging Nu Skin Enterprises 271% rise. Avon Products�(AVP), another multi-level marketer, has gained 21% so far this year, while Tupperware Brands�(TUP) has risen 49%.

Top Valued Stocks To Buy For 2015: Caterpillar Inc.(CAT)

Caterpillar Inc. manufactures and sells construction and mining equipment, diesel and natural gas engines, industrial gas turbines, and diesel-electric locomotives worldwide. It operates through three lines of businesses: Machinery, Engines, and Financial Products. The Machinery business offers construction, mining, and forestry machinery, including track and wheel tractors, track and wheel loaders, pipelayers, motor graders, wheel tractor-scrapers, track and wheel excavators, backhoe loaders, log skidders, log loaders, off-highway trucks, articulated trucks, paving products, skid steer loaders, underground mining equipment, tunnel boring equipment, and related parts. It also manufactures diesel-electric locomotives; and manufactures and services rail-related products and logistics services for other companies. The Engines business provides diesel, heavy fuel, and natural gas reciprocating engines for Caterpillar machinery, electric power generation systems, marine, petrol eum, construction, industrial, agricultural, and other applications. It offers industrial turbines and turbine-related services for oil and gas, and power generation applications. This business also remanufactures Caterpillar engines, machines, and engine components; and offers remanufacturing services for other companies. The Financial Products business provides retail and wholesale financing alternatives for Caterpillar machinery and engines, solar gas turbines, and other equipment and marine vessels, as well as offers loans and various forms of insurance to customers and dealers. It also offers financing for vehicles, power generation facilities, and marine vessels. The company markets its products directly, as well as through its distribution centers, dealers, and distributors. It was formerly known as Caterpillar Tractor Co. and changed its name to Caterpillar Inc. in 1986. Caterpillar Inc. was founded in 1925 and is headquartered in Peoria, Illinois.

Advisors' Opinion:

• [By Raymond Boisvert]

  Caterpillar (NYSE: CAT  ) -- YTD return: -1.62%
  Heavy-equipment manufacturer Caterpillar has had its performance hampered by a hefty decline in overseas demand for its products coupled with falling commodity prices. Falling commodity prices mean tighter margins for mining companies who lose the capital to reinvest in new equipment from Caterpillar. As a result, Caterpillar's mining segment saw a 23% decline in sales in the first quarter. Construction spending has not increased enough to make up for losses incurred in the mining segment. Cost-cutting efforts and layoffs have been implemented to try to salvage some of the bottom line. All of the above has contributed to a lackluster stock performance since the year began.

• [By Dan Caplinger]

  Caterpillar (NYSE: CAT  ) , down 1.1%
  For Caterpillar, the past two months have been quite volatile, with the stock having dropped about 10% only to recover nearly all of that lost ground more recently. Just before earnings, Caterpillar took a big hit when the bottom fell out of the gold market, as gold prices fell more than $140 in a single day. The impact of gold's decline on its mining equipment business could be huge, as miners struggling with much narrower margins will have less money to spend on capital expenditures for Caterpillar equipment. Yet since then, macroeconomic moves to bolster world growth, including rate cuts from the European and Australian central banks, have given investors hope that commodities will bounce back and that mining activity will resume. Now, Caterpillar just needs to see that turn into a reversal of horrendous sales trends in recent months.

• [By Dan Dzombak]

  The Dow Jones Industrial Average (DJINDICES: ^DJI  ) is up after the Australian Central Bank lowered interest rates in an effort to boost the nation's economy. Caterpillar (NYSE: CAT  ) stock is leading the Dow today, as the interest rate cut bodes well for demand in Australia. As of 1:10 p.m. EDT the Dow is up 68 points to 15,037, while the S&P 500 (SNPINDEX: ^GSPC  ) is up 6.5 points to 1,624.

• [By Chris Hill]

  Molex (NASDAQ: MOLX  ) is up big after Koch Industries agreed to buy the company for $7.2 billion in cash. Yum! Brands' (NYSE: YUM  ) same-store sales in China fall 10% in August. Caterpillar (NYSE: CAT  ) shares are up on news that China's exports grew more than 7% in August. And Middleby (NASDAQ: MIDD  ) closes in on a new all-time high. In this segment, the guys discuss four stocks making big moves.